Trial
NCT03325114
Safety and Efficacy of Chlorthalidone in Type 1 Diabetes
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Rochester
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Type 1 Diabetes Mellitus
Intervention
Chlorthalidone
Why stopped
COVID restrictions prohibit further study activies
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-05